Dear Users,

The journal ratings for Impact Factor 2024 have been published.

https://jcr.clarivate.com

Golda Mária

Publication list

Tudóstér co-authors statistics filterable publication list

Export to RIS (EndNote, Mendeley, RefWorks, Zotero etc.)

Upload publications

Request certified publication list

Uploaded publications:

Publications in DEA:

OA:

Date range:

2020-2026

2026

Mótyán, J. A., Golda, M., Mahdi, M., Nashed, N. T., Louis, J. M., Tőzsér, J.: Molecular mechanisms of protease precursor autoprocessing of RNA viruses: a comprehensive review.
Virol. J. 23 (1), 1-23, (article identifier: 96), 2026.

doi DEA WoS Scopus

Journal metrics:

Q1 Infectious Diseases (2025)

Q2 Virology (2025)

2025

Mótyán, J. A., Nagy, T., Veres, Á., Golda, M., Mahdi, M., Tőzsér, J.: Identification of SARS-CoV-2 Main Protease Cleavage Sites in Bovine β-Casein.
Int. J. Mol. Sci. 26 (12), 1-11, (article identifier: 5829), 2025.

doi DEA WoS Scopus

Journal metrics:

Q1 Catalysis

Q1 Computer Science Applications

D1 Inorganic Chemistry

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

D1 Organic Chemistry

Q1 Physical and Theoretical Chemistry

D1 Spectroscopy

2024

Golda, M., Hoffka, G., Cherry, S., Tropea, J. E., Lountos, G. T., Waugh, D. S., Wlodawer, A., Tőzsér, J., Mótyán, J. A.: P1' specificity of the S219V/R203G mutant tobacco etch virus protease.
Proteins. 92 (9), 1085-1096, 2024.

doi DEA WoS Scopus

Journal metrics:

Q1 Biochemistry

Q2 Molecular Biology

Q2 Structural Biology

2021

Kassay, N., Mótyán, J. A., Matúz, K., Golda, M., Tőzsér, J.: Biochemical Characterization, Specificity and Inhibition Studies of HTLV-1, HTLV-2, and HTLV-3 Proteases.
Life (Basel). 11 (2), 1-21, (article identifier: 127), 2021.

doi DEA

Journal metrics:

Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous)

Q2 Ecology, Evolution, Behavior and Systematics

Q2 Paleontology

Q3 Space and Planetary Science

2020

Mahdi, M., Mótyán, J. A., Szojka, Z., Golda, M., Miczi, M., Tőzsér, J.: Analysis of the efficacy of HIV protease inhibitors against SARS-CoV-2·s main protease.
Virol. J. 17 (1), 1-8, (article identifier: 190), 2020.

doi DEA WoS Scopus

Journal metrics:

Q2 Infectious Diseases

Q2 Virology

Golda, M., Mótyán, J. A., Nagy, K., Matúz, K., Nagy, T., Tőzsér, J.: Biochemical characterization of human retroviral-like aspartic protease 1 (ASPRV1).
Biomolecules. 10 (7), 1-25, 2020.

DEA WoS Scopus

Journal metrics:

Q2 Biochemistry

Q2 Molecular Biology

Golda, M., Mótyán, J. A., Mahdi, M., Tőzsér, J.: Functional Study of the Retrotransposon-Derived Human PEG10 Protease.
Int. J. Mol. Sci. 21 (7), 1-22, (article identifier: 2424), 2020.

doi DEA WoS Scopus

Journal metrics:

Q2 Catalysis

D1 Computer Science Applications

D1 Inorganic Chemistry

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

D1 Organic Chemistry

D1 Physical and Theoretical Chemistry

D1 Spectroscopy

Miczi, M., Golda, M., Kunkli, B., Nagy, T., Tőzsér, J., Mótyán, J. A.: Identification of Host Cellular Protein Substrates of SARS-COV-2 Main Protease.
Int. J. Mol. Sci. 21 (24), 1-19, (article identifier: 9523), 2020.

doi DEA WoS Scopus

Journal metrics:

Q2 Catalysis

D1 Computer Science Applications

D1 Inorganic Chemistry

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

D1 Organic Chemistry

D1 Physical and Theoretical Chemistry

D1 Spectroscopy

Golda, M., Mótyán, J. A., Mahdi, M., Tőzsér, J.: Study of the Retrotransposon-Derived Human PEG10 Protease.
Proceedings. 50 (1), 110, 2020.

doi DEA